Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Trigger Point Manual Therapy for the Treatment of Chronic Noncancer Pain in Adults: A Systematic Review and Meta-analysis (2019) |
Auteurs : | Diarmuid Denneny ; Helena C. Frawley ; Katrine Petersen |
Type de document : | Article |
Dans : | Archives of Physical Medicine and Rehabilitation (Vol. 100, n° 3, 2019) |
Article en page(s) : | p. 562-577 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Douleur chronique ; Rééducation et réadaptation |
Mots-clés: | Manipulations de l'appareil locomoteur ; Points de déclenchement |
Résumé : |
Objective To determine the effectiveness of trigger point manual therapy (TPMT) for reducing chronic noncancer pain and associated problems in adults, by analyzing all relevant randomized controlled trials (RCTs). Data Sources We searched databases and clinical trials registers from their inception to May 2017. Study Selection We included RCTs in any language that recruited patients older than 18, with pain of 3 months duration or more. We assessed pain, function, and patient-reported improvement as outcomes. Data Extraction Two authors independently extracted and verified data. Meta-analysis was completed where possible, otherwise data were synthesized narratively. Data Synthesis We combined all data using a random-effects model and assessed the quality of evidence using GRADE. A total of 19 trials (involving 1047 participants) met inclusion criteria, representing TPMT treatment of musculoskeletal, pelvic, and facial pain. No effect was found for short-term pain relief (mean standardized difference −0.53; 95% confidence interval [CI], −1.08 to 0.02). One small study showed a longer-term benefit for pain (mean standardized difference −2.00; 95% CI, −3.40 to −0.60) but with low confidence in the effect. Significant gains emerged for function (mean standardized difference −0.77; 95% CI, −1.27 to −0.26) and in patient global response (odds ratio 3.79; 95% CI, 1.86-7.71) from 4 studies, but not for health-related quality of life. Conclusions Evidence for TPMT for chronic noncancer pain is weak and it cannot currently be recommended. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S0003999318304453 |